Publicaciones

Geraldine Gueron

  1. Antico VG, Gueron G, Cotignola J, Vázquez E. Altered Signaling Pathways in Prostate Cancer Drive Metabolic Fate. International Journal of Scientific Research. September, 2017. In press.
  2. Paez A, Vazquez E, Gueron G. Heme oxygenase 1 governs the cytoskeleton at filopodia: pulling the brakes on the migratory capacity of prostate tumoral cells. Cell Death Discov. 2017 Apr 3;3:17020.
  3. Jaworski FM, Gentilini L, Gueron G, Meiss RP, Ortiz EG, Berguer PM, Ahmed A, Navone NM, Rabinovich GA, Compagno D, Laderach DJ, Vazquez ES. In vivo hemin conditioning targets the vascular and immunological compartments and restrains prostate tumor development.  Clin Cancer Res. 2017 May 16. pii: clincanres.0112.2017. doi: 10.1158/1078-0432.CCR-17-0112. [Epub ahead of print]
  4. Alejandra V Paez, Carla Pallavicini, Federico Schuster, Maria Pia Valacco, Jimena Giudice, Emiliano G Ortiz, Nicolás Anselmino, Estefania Labanca, Maria Binaghi, Marcelo Salierno, Marcelo A Martí, Javier H Cotignola, Anna Woloszynska-Read, Luciana Bruno, Valeria Levi, Nora Navone, Elba S Vazquez, and Geraldine Gueron. Heme oxygenase-1 in the forefront of a multi-molecular network that governs cell–cell contacts and filopodia-induced zippering in prostate cancer. Cell Death Dis. 2016 Dec; 7(12): e2570. Published online 2016 Dec 29. doi: 10.1038/cddis.2016.420
  5. Leonardi DB, Abbate M, Riccheri MC, Nuñez M, Alfonso G, Gueron G, De Siervi A, Vazquez E, Cotignola J. Improving risk stratification of patients with childhood acute lymphoblastic leukemia: Glutathione-S-Transferases polymorphisms are associated with increased risk of relapse. Oncotarget. 2017 Jan 3; 8(1):110-117. doi: 10.18632/oncotarget.8606
  6. Labanca E, De Luca P, Gueron G, Paez A, Moiola CP, Massillo C, Porretti J, Giudice J, Zalazar F, Navone N, Vazquez E, De Siervi A. Mol Cancer Res.  Association of HO-1 and BRCA1 Is Critical for the Maintenance of Cellular Homeostasis in Prostate Cancer.2015 Nov; 13(11):1455-64. doi: 10.1158/1541-7786.MCR-15-0150-T. Epub 2015 Jul 30.
  7. Gueron G, Giudice J, Valacco P, Paez A, Eguero B, Toscani AM; Jaworski F; Coluccio Leskow F; Cotignola J; Marti M; Binaghi M; Navone N; Vazquez E. HEME-OXYGENASE – 1 IMPLICATIONS IN CELL MORPHOLOGY AND THEADHESIVE BEHAVIOR OF PROSTATE CANCER CELLS 2014 Jun; 5(12): 4087–4102. Published online 2014 Mar 16. doi: 10.18632/oncotarget.1826
  8. Gueron G, Avanzo R, Schuster F, Carabelos N, Vazquez E, Fascio M; D’Accorso N. DIFFERENTIALEFFECT OF HETEROCYCLIC D-RIBOFURANOSIDE DERIVATIVES ON HUMAN PROSTATE CANCERCELL VIABILITY AND CELL CYCLE PROGRESSION. Biomedicine and Pharmacotherapy. 2014 Sep;68(7):847-54. doi: 10.1016/j.biopha.2014.08.010. Epub 2014 Aug 19
  9. Gueron G, Cotignola J, Vazquez E. INFLAMMATORY MICROENVIRONMENT IN PROSTATE CARCINOGENESIS. Book chapter of “BOOK TITLE: Advances in Prostate Cancer. (INTECH open access publisher, (2012)) ISBN 980-953-307-719-7.
  10. Elguero, B.; Gueron G.; Giudice, J, Toscani, A.M.; De Luca, P. ; Zalazar, F. ; Coluccio Leskow, F.; Meiss, R.; Navone, N.; De Siervi, A.; Vazquez, E.”UNVEILING THE ASSOCIATION OF STAT3 AND HO-1 IN PROSTATE CANCER: ROLE BEYOND HEME DEGRADATION” Neoplasia (2012) November 2012; Vol. 14, No. 11
  11. Gueron G, De Siervi, A.; Vazquez, E. “Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior”. Prostate Cancer and Prostatic Diseases (2011) Sep;15(3):213-21.
  12. Ferrando M*, Gueron G, F, Elguero B, Giudice, J.; Salles, A.; Coluccio Leskow, F.; Jares-Erijman, E.A.; Colombo, L.; Meiss, R.; Navone, N.; De Siervi, A.; Vazquez, E. “Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer” Angiogenesis (2011). Dec;14(4):467-79.
  13. De Luca P, Vazquez E, Moiola C, Zalazar F, Cotignola F, Gueron G, Gardner K, De Siervi A. “BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer.” Mol Cancer Res (2011) Jun 23. [Epub ahead of print]
  14. Gueron G, A. De Siervi; E.Vazquez. “Key questions in metastasis: new insights in molecular pathways and therapeutic implications”. Current Pharmaceutical Biotechnology Apr 6. (2011) [Epub ahead of print]
  15. Gueron G, De Siervi A, Ferrando M, Salierno M, De Luca P, Elguero B,  Meiss R,  Navone N, Vazquez, E. “Critical role of endogenous heme oxygenase 1 (HO-1) as a tuner of the invasive potential of prostate cancer cells”. Mol. Cancer Res. 7 (2009) 1745-55.
  16. De Siervi A, Idelman G, Tongbai R, De Luca P, Gueron G, Chandramouli1 GVR, Rustici G, Haggerty C, Dzekunova I, Petersen D, Kawasaki E, Kil WK, Camphausen K, Longo D, Gardner K. “Identification of new Rel/NF-kappaB regulatory networks by focused genome location analysis”. Cell Cycle (2009) Volume 8, Issue 13, July 1.
  17. Ge Y, Byun J, De Luca P, Gueron G, Yabe I, Sadiq-Ali S, Figg W, Quintero J, Haggerty C, Li Q, De Siervi A, Gardner K. “Combinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2,4-difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and flavopiridol”. Mol Pharmacol. (2008) 74:872-83. Epub 2008 Jun 12.

 

 

Comentarios cerrados